Abbott Laboratories (ABT): FDA approves ABT’s Freestyle Libre 3

Reply Private New

Next 10 Prev Next

Send PM Follow Ignore

Followers	839
Posts	120669
Boards Moderated	13
Alias Born	09/05/2002

DewDiligence

Re: DewDiligence post# 748

Tuesday, 05/31/2022 12:09:16 PM

Tuesday, May 31, 2022 12:09:16 PM

FDA approves ABT’s Freestyle Libre 3—the most advanced version of the product, which has been approved internationally for several years:

https://finance.yahoo.com/news/abbotts-freestyle-libre-3-receives-120000002.html

• The FreeStyle Libre 3 system is the most accurate 14-day continuous glucose monitor1, with readings sent directly to a smartphone every minute.

• Designed for access and affordability, the FreeStyle Libre 3 system will be available at the same price as previous versions, which is one-third the cost of other competing continuous glucose monitoring systems available today.

ABT’s Freestyle Libre franchise had annualized sales of $4B in 1Q22 (#msg-168608801), making it the largest-selling medical device from any company.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”